Acromus 0.1% Eye Ointment
Marketer
Pharmatak Opthalmics Pvt Ltd
Salt Composition
Tacrolimus (0.1%)
Overview Acromus 0.1% Eye Ointment
Allergic conjunctivitis is treated with Allergicare 0.1% ophthalmic ointment, which modulates the ocular immune response. By reducing the activity of specific immune cells, it diminishes inflammation and associated symptoms like itching, redness, and discomfort. Allergicare 0.1% ophthalmic ointment achieves this by curbing inflammatory mediator release from T lymphocytes, thereby alleviating swelling and redness. Discard the ointment if the container's seal is compromised. Always wash your hands prior to application. Strictly adhere to your doctor's prescribed dosage and duration. Remove contact lenses before application and wait at least 15 minutes before reinsertion. Report any lack of improvement or worsening symptoms after a two-week treatment period. Minor eye irritation and burning are common; report any persistent or worsening side effects. This medication is not recommended during pregnancy or breastfeeding; consult your physician.
Uses of Acromus 0.1% Eye Ointment
Managing allergic conjunctivitis
Major Benefits of Acromus 0.1% Eye Ointment:
Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and schedule. Consult the product label for application instructions prior to use. Keep the applicator tip near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
Common Side effects of Acromus 0.1% Eye Ointment:
- Eye irritation
- Burning sensation
How to use Acromus 0.1% Eye Ointment:
Apply this medication externally only. Administer the prescribed dosage and frequency as directed by your physician. Always consult the product label for application instructions. Position the applicator near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac.
How Acromus 0.1% Eye Ointment works:
Acromus 0.1% ophthalmic ointment modulates the immune response. Its mechanism involves the inhibition of calcineurin, a protein, thereby reducing inflammatory mediator release from T lymphocytes. This action alleviates the signs and symptoms of allergic conjunctivitis.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Acromus 0.1% Eye Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Acromus 0.1% ophthalmic ointment while breastfeeding appears to pose minimal risk. Available data from human studies indicate negligible infant exposure.
DrivingUNSAFE
Using Acromus 0.1% Eye Ointment could reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if such effects are experienced.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Acromus 0.1% Eye Ointment :
Should you forget a dose of Acromus 0.1% ophthalmic ointment, apply it at your earliest convenience. Nevertheless, if your next scheduled application is imminent, omit the missed dose and resume your usual dosing regimen. Avoid administering a double dose.
Facts to Know About Acromus 0.1% Eye Ointment
| Label | Value |
|---|---|
| Chemical Category | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavior Class | Calcineurin inhibitor immunosuppressants |
3,018 People bought this recently